These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6421424)

  • 41. Need stable diabetics mix their insulins?
    Roland JM
    Diabet Med; 1984 May; 1(1):51-3. PubMed ID: 6242778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biosynthetic human insulin in the treatment of diabetes. A double-blind crossover trial in established diabetic patients.
    Clark AJ; Adeniyi-Jones RO; Knight G; Leiper JM; Wiles PG; Jones RH; Keen H; MacCuish AC; Ward JD; Watkins PJ; Cauldwell JM; Glynne A; Scotton JB
    Lancet; 1982 Aug; 2(8294):354-7. PubMed ID: 6124760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of insulin mixtures in type I diabetics: influence of the intermediate acting insulin on the action of short acting insulin.
    Goicolea I; Quiroga A; Vazquez JA
    Diabete Metab; 1987; 13(4):467-70. PubMed ID: 3315768
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of premixed with patient-mixed insulins.
    Corcoran JS; Yudkin JS
    Diabet Med; 1986 May; 3(3):246-9. PubMed ID: 2951178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A method for the determination of plasma insulin antibodies and its application in normal and diabetic subjects.
    Sebriakova M; Little JA
    Diabetes; 1973 Jan; 22(1):30-40. PubMed ID: 4734254
    [No Abstract]   [Full Text] [Related]  

  • 47. Insulin degludec, a long-acting once-daily basal analogue for type 1 and type 2 diabetes mellitus.
    Berard L; MacNeill G
    Can J Diabetes; 2015 Feb; 39(1):4-9. PubMed ID: 25065475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Experiences with monocomponent (MC) insulin in the treatment of juvenile diabetes].
    Aronson S; Engleson G
    Lakartidningen; 1976 Nov; 73(46):3982-4. PubMed ID: 790057
    [No Abstract]   [Full Text] [Related]  

  • 49. Glycaemic control in insulin requiring diabetes patients receiving exclusive enteral tube feeding in an acute hospital setting.
    Murphy PM; Moore E; Flanagan DE
    Diabetes Res Clin Pract; 2014 Mar; 103(3):426-9. PubMed ID: 24462281
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ultralente insulin treatment of transient neonatal diabetes mellitus.
    Mitamura R; Kimura H; Murakami Y; Nagaya K; Makita Y; Okuno A
    J Pediatr; 1996 Feb; 128(2):268-70. PubMed ID: 8636827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of insulin-dependent diabetes using an injection pen: control, problems and patient preferences.
    Fisken RA; Goulbourn J
    Diabetes Res; 1989 Aug; 11(4):195-7. PubMed ID: 2696619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of early-morning hyperglycemia in type 1 diabetics with amorphous zinc insulin (Semilente) at bedtime.
    Strasser D; Nützi E; Spinas GA; Berger W
    Horm Res; 1993; 39(5-6):173-8. PubMed ID: 8314199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of monopeak insulin preparations in patients with type-1 diabetes mellitus].
    Pliats OM; Perelygina AA; Starosel'tseva LK
    Probl Endokrinol (Mosk); 1984; 30(3):3-6. PubMed ID: 6377294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Miscibility of semisynthetic human ultralente insulin with short-acting insulin in insulin-dependent diabetic patients.
    Lunetta M; di Mauro M; Crimi S; Sudano L; Mughini L
    Acta Diabetol Lat; 1988; 25(3):263-9. PubMed ID: 3071068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
    Ledermann H; Höxter G
    Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhaled insulin: Exubera.
    Odegard PS; Capoccia KL
    Ann Pharmacother; 2005 May; 39(5):843-53. PubMed ID: 15827072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
    Bode BW; Johnson JA; Hyveled L; Tamer SC; Demissie M
    Diabetes Technol Ther; 2017 Jan; 19(1):25-33. PubMed ID: 28055230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin antibodies and clinical complications in diabetics treated for five years with lente or sulfated insulin.
    Little JA; Lee R; Sebriakova M; Csima A
    Diabetes; 1977 Oct; 26(10):980-8. PubMed ID: 561729
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparative double-blind trial of the effectiveness and antigenicity of semisynthetic human insulin and purified porcine insulin in newly treated diabetic subjects.
    Larkins RG; Zajac J; Saunders R; Read A; Hopper JL
    Aust N Z J Med; 1986 Apr; 16(2):206-10. PubMed ID: 3530226
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human insulin and porcine insulin in the treatment of diabetic children: comparison of metabolic control and insulin antibody production.
    Mann NP; Johnston DI; Reeves WG; Murphy MA
    Br Med J (Clin Res Ed); 1983 Nov; 287(6405):1580-2. PubMed ID: 6416511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.